The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

Haplo-cord HCT offered improved 2-year OS (72.7% vs 61.0%) and DFS (67.0% vs 49.6%) compared with haplo HCT alone.

October 12, 2025 - PORTERVILLE, Calif. — A cutting-edge cancer treatment that reprograms the body’s own immune cells saved a Porterville child’s life — and it’s coming soon to Valley Children’s, ...

The award named after German businessman Bernard Broermann, recognizes outstanding scientific achievements in the field of ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

Mid Valley High School grad Eddie Kaufman, a star on the baseball field and golf course, and among family and friends, died ...

Adult T-cell leukemia–lymphoma (ATL) is a peripheral T-cell malignancy, closely associated with human T-cell lymphotropic virus type I infection. Clinically, ATL is classified into four subtypes: ...

Eddie Kaufman played hard on the field, but fought even harder off the diamond before losing his fight with leukemia at the ...

A 12-year-old girl diagnosed with acute lymphoblastic leukemia was successfully treated for the first time with CAR-T immune cell therapy by doctors at the Ho Chi Minh City Blood Transfusion and ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical ...